Zhenyi Hu

Zhenyi Hu

Auto-generated profile, based on publicly available information

Zhenyi Hu

Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in ACS Chemical Biology
Verified
Journal Article
Closed access
Po-Han ChenPo-Han Chen
Po-Han Chen
ZHZhenyi Hu
Zhenyi Hu
EAElvira An
Elvira An
IOIfunanya Okeke
Ifunanya Okeke
SZSijin Zheng
Sijin Zheng
CCCraig M. Crews
Craig M. Crews

29 March 2024 in Science Advances
Verified
Journal Article
Open access
ZHZhenyi Hu
Zhenyi Hu
Po-Han ChenPo-Han Chen
Po-Han Chen
WLWenxue Li
Wenxue Li
MKMackenzie Krone
Mackenzie Krone
SZSijin Zheng
Sijin Zheng
CCCraig M. Crews
Craig M. Crews
We recently developed a heterobifunctional approach [phosphorylation targeting chimeras (PhosTACs)] to achieve the targeted protein dephosphorylation (TPDephos). Here, we envisioned combining the inhibitory effects of receptor tyrosine kinase inhibitors (RTKIs) and the active dephosphorylation by phosphatases to achieve dual inhibition of kinases. We report an example of tyrosine phosphatase–based TPDephos and the effective epidermal growth factor receptor (EGFR) tyrosine dephosphorylation. We also used phosphoproteomic approaches to study the signaling transductions affected by PhosTAC-related molecules at the proteome-wide level. This work demonstrated the differential signaling pathways inhibited by PhosTAC compared with the TKI, gefitinib. Moreover, a covalent PhosTAC selective for mutated EGFR was developed and showed its inhibitory potential for dysregulated EGFR. Last, EGFR PhosTACs, consistent with EGFR dephosphorylation profiles, induced apoptosis and inhibited cancer cell viability during prolonged PhosTAC treatment. PhosTACs showcased their potential of modulating RTKs activity, expanding the scope of bifunctional molecule utility.